Drug Shortage Report for REOPRO

Last updated on 2018-06-15 History
Report ID 45073
Drug Identification Number 02216973
Brand name REOPRO
Common or Proper name Abciximab
Company Name JANSSEN INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ABCIXIMAB
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1x5
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-05-04
Actual start date
Estimated end date 2019-12-31
Actual end date 2018-06-14
Shortage status Resolved
Updated date 2018-06-15
Company comments
Health Canada comments
Contact Address 19 GREEN BELT DRIVE
TORONTO, ONTARIO
CANADA M3C 1L9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-06-15 English Compare
v7 2018-06-14 French Compare
v6 2018-06-14 English Compare
v5 2018-05-05 English Compare
v4 2018-05-04 French Compare
v3 2018-05-04 English Compare
v2 2018-04-05 French Compare
v1 2018-04-05 English Compare